Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$9.99 - $18.71 $357,791 - $670,098
-35,815 Reduced 16.72%
178,438 $3.31 Million
Q2 2023

Aug 03, 2023

BUY
$9.17 - $19.29 $893,405 - $1.88 Million
97,427 Added 83.39%
214,253 $2.37 Million
Q1 2023

May 04, 2023

SELL
$12.53 - $21.71 $540,569 - $936,612
-43,142 Reduced 26.97%
116,826 $1.57 Million
Q4 2022

Feb 13, 2023

SELL
$11.61 - $16.11 $17,728 - $24,599
-1,527 Reduced 0.95%
159,968 $1.98 Million
Q3 2022

Nov 03, 2022

BUY
$12.21 - $19.7 $1.54 Million - $2.48 Million
125,752 Added 351.82%
161,495 $2.25 Million
Q2 2022

Aug 12, 2022

SELL
$11.23 - $19.59 $490,088 - $854,927
-43,641 Reduced 54.97%
35,743 $494,000
Q1 2022

May 16, 2022

BUY
$13.37 - $17.79 $498,767 - $663,655
37,305 Added 88.65%
79,384 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$14.28 - $19.53 $315,730 - $431,808
22,110 Added 110.72%
42,079 $686,000
Q3 2021

Nov 09, 2021

SELL
$12.99 - $20.47 $674,245 - $1.06 Million
-51,905 Reduced 72.22%
19,969 $296,000
Q2 2021

Aug 13, 2021

SELL
$15.46 - $24.5 $448,216 - $710,304
-28,992 Reduced 28.74%
71,874 $1.44 Million
Q1 2021

May 13, 2021

BUY
$19.33 - $37.75 $149,401 - $291,769
7,729 Added 8.3%
100,866 $2.33 Million
Q4 2020

Feb 11, 2021

SELL
$24.48 - $42.47 $5.03 Million - $8.73 Million
-205,476 Reduced 68.81%
93,137 $2.3 Million
Q3 2020

Nov 12, 2020

BUY
$39.09 - $53.44 $3.42 Million - $4.67 Million
87,367 Added 41.36%
298,613 $12.4 Million
Q2 2020

Aug 12, 2020

SELL
$46.7 - $92.04 $1.8 Million - $3.55 Million
-38,527 Reduced 15.42%
211,246 $10.1 Million
Q1 2020

May 13, 2020

BUY
$48.35 - $118.68 $8.1 Million - $19.9 Million
167,574 Added 203.86%
249,773 $15.7 Million
Q4 2019

Feb 10, 2020

BUY
$57.36 - $124.1 $2.31 Million - $4.99 Million
40,236 Added 95.88%
82,199 $10.2 Million
Q3 2019

Nov 14, 2019

SELL
$58.69 - $80.46 $383,832 - $526,208
-6,540 Reduced 13.48%
41,963 $2.78 Million
Q2 2019

Aug 14, 2019

SELL
$77.77 - $120.68 $3.01 Million - $4.67 Million
-38,735 Reduced 44.4%
48,503 $3.86 Million
Q1 2019

May 15, 2019

BUY
$91.83 - $120.68 $2.78 Million - $3.65 Million
30,253 Added 53.09%
87,238 $9.76 Million
Q4 2018

Feb 14, 2019

BUY
$85.79 - $126.46 $554,889 - $817,943
6,468 Added 12.8%
56,985 $5.74 Million
Q3 2018

Nov 14, 2018

BUY
$88.49 - $127.55 $2.38 Million - $3.43 Million
26,901 Added 113.91%
50,517 $6.38 Million
Q2 2018

Aug 14, 2018

SELL
$60.0 - $85.67 $3.76 Million - $5.37 Million
-62,693 Reduced 72.64%
23,616 $1.98 Million
Q1 2018

May 15, 2018

BUY
$52.72 - $67.25 $4.16 Million - $5.31 Million
78,954 Added 1073.47%
86,309 $5.31 Million
Q4 2017

Feb 14, 2018

BUY
$58.2 - $72.76 $292,455 - $365,619
5,025 Added 215.67%
7,355 $429,000
Q3 2017

Nov 14, 2017

BUY
$57.01 - $118.75 $132,833 - $276,687
2,330
2,330 $135,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.